Literature DB >> 11882797

A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century.

T L Palmieri1, D G Greenhalgh, J R Saffle, R J Spence, M D Peck, J C Jeng, D W Mozingo, C J Yowler, R L Sheridan, D H Ahrenholz, D M Caruso, K N Foster, R J Kagan, D W Voigt, G F Purdue, J L Hunt, S Wolf, F Molitor.   

Abstract

Toxic epidermal necrolysis (TEN) is a potentially fatal disorder that involves large areas of skin desquamation. Patients with TEN are often referred to burn centers for expert wound management and comprehensive care. The purpose of this study was to define the presenting characteristics and treatment of TEN before and after admission to regional burn centers and to evaluate the efficacy of burn center treatment for this disorder. A retrospective multicenter chart review was completed for patients admitted with TEN to 15 burn centers from 1995 to 2000. Charts were reviewed for patient characteristics, non-burn hospital and burn center treatment, and outcome. A total of 199 patients were admitted. Patients had a mean age of 47 years, mean 67.7% total body surface area skin slough, and mean Acute Physiology and Chronic Health Evaluation (APACHE II) score of 10. Sixty-four patients died, for a mortality rate of 32%. Mortality increased to 51% for patients transferred to a burn center more than one week after onset of disease. Burn centers and non-burn hospitals differed in their use of enteral nutrition (70 vs 12%, respectively, P < 0.05), prophylactic antibiotics (22 vs 37.9%, P < 0.05), corticosteroid use (22 vs 51%, P < 0.05), and wound management. Age, body surface area involvement, APACHE II score, complications, and parenteral nutrition before transfer correlated with increased mortality. The treatment of TEN differs markedly between burn centers and non-burn centers. Early transport to a burn unit is warranted to improve patient outcome.

Entities:  

Mesh:

Year:  2002        PMID: 11882797     DOI: 10.1097/00004630-200203000-00004

Source DB:  PubMed          Journal:  J Burn Care Rehabil        ISSN: 0273-8481


  31 in total

1.  [Treatment of toxic epidermal necrolysis. Experience with 9 patients with consideration of intravenous immunoglobulin].

Authors:  P Spornraft-Ragaller; H Theilen; G S Gottschlich; M Ragaller
Journal:  Hautarzt       Date:  2006-03       Impact factor: 0.751

2.  60-year-old man with rash.

Authors:  Devin E Shahverdian; Constantinos P Anastassiades; Joseph C Charles
Journal:  Mayo Clin Proc       Date:  2009-09       Impact factor: 7.616

3.  Systematic review of treatments for Stevens-Johnson syndrome and toxic epidermal necrolysis using the SCORTEN score as a tool for evaluating mortality.

Authors:  Jean-Claude Roujeau; Sylvie Bastuji-Garin
Journal:  Ther Adv Drug Saf       Date:  2011-06

4.  Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10.

Authors:  Megan H Noe; Misha Rosenbach; Rebecca A Hubbard; Arash Mostaghimi; Adela R Cardones; Jennifer K Chen; Jonathan Cotliar; Mark D P Davis; Arturo Dominguez; Lindy P Fox; Lauren C Hughey; Benjamin H Kaffenberger; Daniela Kroshinsky; Bernice Y Kwong; Daniel D Miller; Amy Musiek; Alex G Ortega-Loayza; Victoria R Sharon; Kanade Shinkai; Erika M Summers; Karolyn A Wanat; David A Wetter; Scott Worswick; David J Margolis; Joel M Gelfand; Robert G Micheletti
Journal:  JAMA Dermatol       Date:  2019-04-01       Impact factor: 10.282

5.  Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and Treatment With a Biologic: A Case Report.

Authors:  Ian Chong; Alice Chao
Journal:  Perm J       Date:  2017

6.  A Case of Toxic Epidermal Necrolysis Successfully Treated with Low Dose Intravenous Immunoglobulins and Systemic Corticosteroid.

Authors:  Lutfi Al-Kathiri; Varghese Mercyamma; Tasneem Al-Najjar
Journal:  Oman Med J       Date:  2018-07

7.  Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Guide for Nurses.

Authors:  Leah M Hanson; Amanda P Bettencourt
Journal:  AACN Adv Crit Care       Date:  2020-09-15

8.  Management of dysphagia in toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS).

Authors:  Nicola A Clayton; Peter J Kennedy
Journal:  Dysphagia       Date:  2007-02-08       Impact factor: 3.438

9.  Fatal toxic epidermal necrolysis in autoimmune polyglandular syndrome type I.

Authors:  A Porzionato; S Zancaner; C Betterle; S D Ferrara
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

10.  Evaluation of the extent of under-reporting of serious adverse drug reactions: the case of toxic epidermal necrolysis.

Authors:  Nicole Mittmann; Sandra R Knowles; Manuel Gomez; Joel S Fish; Robert Cartotto; Neil H Shear
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.